SYSTEMATIC REVIEW OF THE GLOBAL ECONOMIC BURDEN OF RARE DISEASES

Read full text Summarise with VIRAT
Authors: Natacha Regina de Moraes Cerchiari, Ana Carolina Nonato, Kelvin Hiromiti Albuquerque Yokota, Matheus Almeida, Patrícia Coelho de Soárez
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This project is a systematic review aimed at evaluating the global economic burden of rare diseases on healthcare systems and society. The review will synthesize evidence from cost-of-illness and budget impact analysis studies published between 2016 and 2025, focusing on direct medical, direct non-medical, and indirect costs. A comprehensive search will be conducted in MEDLINE, Embase, LILACS, and Web of Science, without language restrictions. Study selection and data extraction will be performed independently by reviewers following PRISMA-P guidelines. This study seeks to provide an up-to-date synthesis of the economic impact of rare diseases to support evidence-based decision-making and health policy development.

Fields of Study & Subjects

Health Systems Economic Evaluations Quality of Life Economic and Financial Impacts of Cancer Genomics and Rare Diseases

Publication details

Publication date
1 January 2026
Language
EN
Document type
Preprint